insights_auto
Bakit bumaba ang ARX 2.80%?
Tingnan ang Higit pang Detalyechevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.52
arrow_downward
-2.80%(-0.015) 1D
Okt 8, 4:10:20 PM GMT+11 · AUD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ARX...
Buksan
A$0.54
Mataas
A$0.54
Mababa
A$0.52
Mkt. cap
177.66M
Avg. na dami
190.04K
Dami
243.14K
P/E ratio
50.29
Mataas nang 52-wk
A$0.80
Mababa nang 52-wk
A$0.48
EPS
A$0.01
Mga natitirang share
345.90M
Bilang ng mga empleyado
261
Buksan
A$0.54
Mataas
A$0.54
Mababa
A$0.52
Mkt. cap
177.66M
Avg. na dami
190.04K
Dami
243.14K
P/E ratio
50.29
Mataas nang 52-wk
A$0.80
Mababa nang 52-wk
A$0.48
EPS
A$0.01
Mga natitirang share
345.90M
Bilang ng mga empleyado
261
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TipRanks
·
1 araw ang nakalipas
Aroa Biosurgery Outlines Interim MASTRR Study Update and Investor Guidance
Kalkine Media
·
2 araw ang nakalipas
ASX Healthcare Stock Aroa Biosurgery (ASX:ARX) Has the Market Watching
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Tungkol sa Aroa Biosurgery Ltd